Literature DB >> 2579225

Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.

A S Krajewski, K Guy, A E Dewar, D Cossar.   

Abstract

Twenty cases of B-cell non-Hodgkin's lymphoma (NHL) were evaluated by immunohistochemical staining of frozen sections with a panel of anti MHC class II monoclonal antibodies (MCA). These studies showed marked differences in the expression of class II antigens both between different cases and within the population of cells of individual cases. In all of the cases studied the majority of the tumour cells reacted with MCAs directed against determinants common to the products of SB and DR loci. However, MCAs specific for DC determinants failed to react with 3/20 cases and in several other cases stained only a minority of cells. Absent or reduced expression of DC antigens was most marked in lymphocytic lymphoma; however, in centroblastic-centrocytic and centroblastic lymphomas, DC antigens could be detected on the majority of cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579225     DOI: 10.1002/path.1711450206

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  MHC class II antigen and immunoglobulin expression in spontaneous phenotypic variants of the Burkitt's lymphoma cell line Namalwa.

Authors:  K Guy; P G Middleton; L J Docherty; C L De Angelis; C M Steel
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

2.  Immunohistological studies of lymphoproliferative lesions in a fatal case of Epstein-Barr virus infection.

Authors:  P Morgan-Capner; J A Morris; M B McIllmurray; J A Thomas; D H Crawford; T Azim
Journal:  J Clin Pathol       Date:  1986-12       Impact factor: 3.411

3.  Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma.

Authors:  M E Smith; C S Holgate; J M Williamson; I Grigor; P Quirke; C C Bird
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

4.  Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.

Authors:  K Guy; R R Meehan; A E Dewar; D Larhammar
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

5.  Biological characterization of human bone tumors. VIII. Expression of HLA-DR antigens in bone tumors and tumor-like lesions.

Authors:  M Petzsch; J Vassallo; A Roessner; G Zwadlo; C Sorg; E Vollmer; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.

Authors:  P Möller; B Lämmler; B Herrmann; H F Otto; G Moldenhauer; F Momburg
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

7.  Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.

Authors:  K Guy; L J Docherty; A E Dewar
Journal:  Clin Exp Immunol       Date:  1986-02       Impact factor: 4.330

Review 8.  Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.

Authors:  K Guy; A S Krajewski; A E Dewar
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

9.  Imbalanced MHC class II molecule expression at surface of murine B cell lymphomas.

Authors:  M Zijlstra; W L Vasmel; M Voormanns; R E de Goede; H J Schoenmakers; J Nieland; R M Slater; C J Melief
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.